Funding Rounds
Enterprise Therapeutics

Enterprise Therapeutics Series A (2015, $2M)

Enterprise Therapeutics

Developer of drugs to treat respiratory diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $2.00M